Abstract
This Practice Point commentary discusses a retrospective study by Oh et al. in which the consequences of using statins in patients with myasthenia gravis (MG) were examined. Out of 170 patients with MG seen at a single hospital center during a 2.5-year period, 54 used statins. Six of these patients reported a worsening of MG symptoms within 8 weeks after receiving statins; in two cases the worsening was associated with a confirmed increase in serum acetylcholine receptor antibody concentration. A further seven patients retrospectively reported temporary muscle aching during the first 8 weeks after statin treatment. This effect was less clearly attributable to the drugs. The effects of statins on MG symptoms were believed to be mediated by the immune system. Statins should be used for the same indications in patients with MG as in those without the condition. However, patients with MG should be informed about the possibility of MG exacerbation, and the statins should be withdrawn if this occurs.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Oh SJ et al. (2008) Statins may aggravate myasthenia gravis. Muscle Nerve 38: 1101–1107
Sousa ED et al. (2008) More evidence for the association between statins and myasthenia gravis. Muscle Nerve 38: 1085–1086
Baigent C et al. (2005) Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90 056 participants in 14 randomised trials of statins. Lancet 366: 1267–1278
Buettner C et al. (2008) Prevalence of musculoskeletal pain and statin use. J Gen Intern Med 23: 1182–1186
Noël B (2007) Lupus erythematosus and other autoimmune diseases related to statin therapy: a systematic review. J Eur Acad Dermatol Venereol 21: 17–24
Hendrix S et al. (2007) The role of T helper cells in neuroprotection and regeneration. J Neuroimmunol 184: 100–112
Wilensky RL et al. (2007) The molecular basis of vulnerable plaque: potential therapeutic role for immunomodulation. Curr Opin Cardiol 22: 545–551
Mira E et al. (2008) Statins induce regulatory T cell recruitment via a CCL1 dependent pathway. J Immunol 181: 3524–3534
Drug consumption in Norway [http://www.legemiddelforbruk.no/english/]
Author information
Authors and Affiliations
Ethics declarations
Competing interests
The author declares no competing financial interests.
Rights and permissions
About this article
Cite this article
Gilhus, N. Is it safe to use statins in patients with myasthenia gravis?. Nat Rev Neurol 5, 8–9 (2009). https://doi.org/10.1038/ncpneuro0988
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/ncpneuro0988
This article is cited by
-
The Management of Hypercholesterolemia in Patients with Neuromuscular Disorder
Current Atherosclerosis Reports (2023)